ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

RenovoRx, Inc. - Common Stock (NQ:RNXT)

0.8566 -0.0434 (-4.82%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	315,220
Open	0.9100
Bid (Size)	0.8700 (500)
Ask (Size)	0.9200 (100)
Prev. Close	0.9000
Today's Range	0.8566 - 0.9299
52wk Range	0.7006 - 1.450
Shares Outstanding	36,649,916
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

January 08, 2026

From Equity Insider

Via GlobeNewswire

Performance

YTD	+2.6%	+2.6%
1 Month	-26.2%	-26.2%
3 Month	-12.4%	-12.4%
6 Month	-25.5%	-25.5%
1 Year	-13.5%	-13.5%

More News

Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025

December 08, 2025

Via ACCESS Newswire

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025

December 01, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 14, 2025

Via Benzinga

RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop ↗

November 13, 2025

Via Chartmill

RenovoRx (RNXT) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

September 16, 2025

Via ACCESS Newswire

iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

September 09, 2025

Via ACCESS Newswire

Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗

September 08, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

September 03, 2025

Via Chartmill

RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025

August 20, 2025

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 15, 2025

Via Benzinga

Gapping stocks in Friday's session ↗

August 15, 2025

Via Chartmill

What's going on in today's pre-market session ↗

August 15, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 15, 2025

Via Benzinga

RenovoRx Revenue Jumps 28 Percent in Q2 ↗

August 14, 2025

Via The Motley Fool

RenovoRx Inc. (NASDAQ:RNXT) Q2 2025 Earnings: Revenue Surpasses Estimates, Shares Climb on Positive Results ↗

August 14, 2025

Via Chartmill

RenovoRx Reports Commercial Revenue Growth in the Second Quarter 2025 and Announces Positive Independent Data Monitoring Committee Recommendation to Continue Pivotal Phase III TIGeR-PaC Trial Based on Interim Data Review

August 14, 2025

From RenovoRx, Inc.

Via Business Wire

RenovoRx Launches Multi-Center Post-Marketing Registry Study to Evaluate Cancer Treatment Delivered by RenovoCath® Device to Solid Tumors

July 28, 2025

From RenovoRx, Inc.

Via Business Wire

RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET

July 14, 2025

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 27, 2025

Via Benzinga

Frequently Asked Questions

Is RenovoRx, Inc. - Common Stock publicly traded?

Yes, RenovoRx, Inc. - Common Stock is publicly traded.

What exchange does RenovoRx, Inc. - Common Stock trade on?

RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for RenovoRx, Inc. - Common Stock?

The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market

What is the current price of RenovoRx, Inc. - Common Stock?

The current price of RenovoRx, Inc. - Common Stock is 0.8566

When was RenovoRx, Inc. - Common Stock last traded?

The last trade of RenovoRx, Inc. - Common Stock was at 04/24/26 04:00 PM ET

What is the market capitalization of RenovoRx, Inc. - Common Stock?

The market capitalization of RenovoRx, Inc. - Common Stock is 31.39M

How many shares of RenovoRx, Inc. - Common Stock are outstanding?

RenovoRx, Inc. - Common Stock has 31M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.